Bhattacharyya Neil
Division of Otolaryngology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Laryngoscope. 2006 Jul;116(7 Pt 2 Suppl 110):1-22. doi: 10.1097/01.mlg.0000224508.59725.19.
OBJECTIVES/HYPOTHESIS: The objectives of this prospective, double-blind diagnostic cohort study were to explore the relationship between patients' reported symptoms of chronic rhinosinusitis (CRS) and radiographic findings in CRS to define clinically based diagnostic criteria for CRS and to determine a classification scheme that would allow for the accurate diagnosis of patients with CRS.
A prospective series of adult patients undergoing evaluation for potential chronic rhinosinusitis was studied. Patients' symptoms were tabulated with the Rhinosinusitis Symptom Inventory (RSI), which records symptoms associated with CRS on a Likert scale (5 = maximally severe). Medication and resource utilization were also tabulated. Scores for nasal, facial, oropharyngeal, systemic, and total symptom domains were computed (100 = maximum severity). Concurrent paranasal sinus computed tomography was obtained for each patient and scored according to the Lund-McKay system with reviewer blinding. Patients were classified as normal or representing true CRS according to previously published diagnostic radiographic criteria under two analyses. In analysis 1, Lund scores < or = 1 were considered nondiseased and scores > or = 2 were considered as representing true CRS. In analysis 2, Lund scores < or = 3 represented normal and scores > or = 4 represented true CRS. For each analysis, univariate statistics were computed to determine differences among patients' reported symptoms with and without true CRS. Subsequently, classification analysis using classification regression trees was conducted to determine heuristics among clinically based criteria for the diagnosis of CRS.
Seven hundred three adult patients were enrolled (mean age, 43.1 years). The most commonly reported symptoms in order of decreasing severity and presence were nasal obstruction, nasal congestion, discharge, fatigue, headache, facial pressure, and dysosmia, all with mean severity scores > or = 2.0. Patients were previously treated for approximately 3 months each with topical nasal steroids, oral antihistamines, and oral antibiotics. Patients missed substantial workdays (mean, 3.8/year) and incurred significant physician visits (mean, 3.5/year) as a result of CRS. The nasal symptom domain exhibited the greatest severity (51.8) followed closely by the facial symptom domain (47.3). According to the analysis 1, 144 (20.5%) patients were classified as normal and 559 (79.5%) as true CRS. Only the presence of polyps (P < .001) and dysosmia (P = .008) distinguished between normal and diseased patients; there were no significant differences between groups for the other symptoms and RSI domains. Classification analysis revealed that the presence of polyps, absence of dental pain, and low congestion/obstruction scores in the presence of dental pain predicted true CRS. Finally, a history of extended antibiotic courses before presentation also predicted true CRS. In the second analysis, 243 (34.6%) were normal versus 460 (65.4%) with true CRS. Only polyp presence and dysosmia exhibited statistically significant differences between normal and diseased patients (P < .001). The mean RSI nasal domain was higher for true patients with CRS (P = .01). Classification analysis identified polyp presence and dysosmia score >2 effectively predicted CRS. Fatigue < or = 2, discharge < or = 4, and obstruction < or = 3 further predicted for CRS. Symptoms despite a > or = 5.5-week trial of nasal steroids also predicted CRS. Other major and minor symptoms, RSI domains, and resource factors failed to influence diagnostic classification.
The diagnosis of CRS based on symptom criteria is difficult because most symptoms (other than dysosmia) do not distinguish between radiographically normal and diseased patients. A classification scheme for CRS based on the presence or absence of polyps is valid. It is possible to classify patients with true CRS based on symptoms, but this requires complicated heuristics. Corroborating radiographic evidence should be required to establish the diagnosis of CRS before long periods of therapy or surgical intervention.
目的/假设:本前瞻性、双盲诊断队列研究的目的是探讨慢性鼻-鼻窦炎(CRS)患者报告的症状与CRS影像学表现之间的关系,以确定基于临床的CRS诊断标准,并确定一种能够准确诊断CRS患者的分类方案。
对一系列接受潜在慢性鼻-鼻窦炎评估的成年患者进行前瞻性研究。使用鼻-鼻窦炎症状量表(RSI)将患者的症状制成表格,该量表以李克特量表(5 = 最严重)记录与CRS相关的症状。还将药物治疗和资源利用情况制成表格。计算鼻、面部、口咽、全身和总症状领域的得分(100 = 最大严重程度)。为每位患者进行同期鼻窦计算机断层扫描,并根据Lund-McKay系统进行评分,阅片者设盲。根据先前发表的诊断影像学标准,在两种分析中将患者分类为正常或代表真正的CRS。在分析1中,Lund评分≤1被认为无疾病,评分≥2被认为代表真正的CRS。在分析2中,Lund评分≤3代表正常,评分≥4代表真正的CRS。对于每种分析,计算单变量统计量以确定有和没有真正CRS的患者报告症状之间的差异。随后,使用分类回归树进行分类分析,以确定基于临床的CRS诊断标准之间的启发式方法。
纳入703例成年患者(平均年龄43.1岁)。按严重程度和出现频率递减顺序排列,最常报告的症状为鼻塞、鼻充血、流涕、疲劳、头痛、面部压迫感和嗅觉障碍,所有症状的平均严重程度评分均≥2.0。患者此前分别接受局部鼻用类固醇、口服抗组胺药和口服抗生素治疗约3个月。由于CRS,患者错过大量工作日(平均每年3.8天),并进行大量门诊就诊(平均每年3.5次)。鼻症状领域的严重程度最高(51.8),紧随其后的是面部症状领域(47.3)。根据分析1,144例(20.5%)患者被分类为正常,559例(79.5%)为真正的CRS。只有息肉的存在(P <.001)和嗅觉障碍(P =.008)可区分正常和患病患者;其他症状和RSI领域在两组之间无显著差异。分类分析显示,息肉的存在、无牙痛以及牙痛时低充血/鼻塞评分可预测真正的CRS。最后,就诊前长期使用抗生素的病史也可预测真正的CRS。在第二次分析中,243例(34.6%)为正常,460例(65.4%)为真正的CRS。只有息肉的存在和嗅觉障碍在正常和患病患者之间表现出统计学显著差异(P <.001)。真正的CRS患者的RSI鼻领域平均值更高(P =.01)。分类分析确定息肉的存在和嗅觉障碍评分>2可有效预测CRS。疲劳≤2、流涕≤4和鼻塞≤3进一步预测CRS。在接受鼻用类固醇≥5.5周试验后仍有症状也可预测CRS。其他主要和次要症状、RSI领域及资源因素未影响诊断分类。
基于症状标准诊断CRS很困难,因为大多数症状(嗅觉障碍除外)无法区分影像学正常和患病患者。基于息肉存在与否的CRS分类方案是有效的。根据症状对真正的CRS患者进行分类是可能的,但这需要复杂的启发式方法。在进行长期治疗或手术干预之前,应要求有确凿的影像学证据来确立CRS的诊断。